|
Name |
Coleon U 12-methyl ether
|
Molecular Formula | C21H28O5 | |
IUPAC Name* |
5,8,10-trihydroxy-6-methoxy-1,1,4a-trimethyl-7-propan-2-yl-3,4-dihydro-2H-phenanthren-9-one
|
|
SMILES |
CC(C)C1=C(C2=C(C(=C1OC)O)C3(CCCC(C3=C(C2=O)O)(C)C)C)O
|
|
InChI |
InChI=1S/C21H28O5/c1-10(2)11-14(22)12-13(16(24)18(11)26-6)21(5)9-7-8-20(3,4)19(21)17(25)15(12)23/h10,22,24-25H,7-9H2,1-6H3
|
|
InChIKey |
QWFMIWDUMBELIV-UHFFFAOYSA-N
|
|
Synonyms |
Coleon U 12-methyl ether; NSC647732; 5,8,10-trihydroxy-7-isopropyl-6-methoxy-1,1,4a-trimethyl-3,4-dihydro-2H-phenanthren-9-one; (R)-2,3,4,4a-tetrahydro-5,8, 10-trihydroxy-6-methoxy-1,1, 4a-trimethyl-7-(1-methylethyl)-9(1H)-phenanthrenone
|
|
CAS | NA | |
PubChem CID | 495262 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 360.4 | ALogp: | 5.4 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 87.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 26 | QED Weighted: | 0.636 |
Caco-2 Permeability: | -4.789 | MDCK Permeability: | 0.00001830 |
Pgp-inhibitor: | 0.58 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.026 | 20% Bioavailability (F20%): | 0.012 |
30% Bioavailability (F30%): | 0.018 |
Blood-Brain-Barrier Penetration (BBB): | 0.059 | Plasma Protein Binding (PPB): | 99.81% |
Volume Distribution (VD): | 0.551 | Fu: | 1.50% |
CYP1A2-inhibitor: | 0.466 | CYP1A2-substrate: | 0.943 |
CYP2C19-inhibitor: | 0.573 | CYP2C19-substrate: | 0.816 |
CYP2C9-inhibitor: | 0.756 | CYP2C9-substrate: | 0.902 |
CYP2D6-inhibitor: | 0.467 | CYP2D6-substrate: | 0.279 |
CYP3A4-inhibitor: | 0.344 | CYP3A4-substrate: | 0.346 |
Clearance (CL): | 1.115 | Half-life (T1/2): | 0.076 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.045 |
Drug-inuced Liver Injury (DILI): | 0.487 | AMES Toxicity: | 0.099 |
Rat Oral Acute Toxicity: | 0.309 | Maximum Recommended Daily Dose: | 0.497 |
Skin Sensitization: | 0.746 | Carcinogencity: | 0.045 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.874 |
Respiratory Toxicity: | 0.958 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001048 | 0.797 | D0WY9N | 0.289 | ||||
ENC002308 | 0.323 | D01CKY | 0.234 | ||||
ENC005919 | 0.312 | D01XWG | 0.213 | ||||
ENC001084 | 0.304 | D0R6RC | 0.213 | ||||
ENC004922 | 0.296 | D06GCK | 0.212 | ||||
ENC000709 | 0.296 | D0T5XN | 0.211 | ||||
ENC005342 | 0.295 | D08NQZ | 0.206 | ||||
ENC002036 | 0.290 | D07MGA | 0.206 | ||||
ENC005550 | 0.290 | D05AFR | 0.204 | ||||
ENC002307 | 0.290 | D02GAC | 0.203 |